: Novavax’s stock rallies after the company names new CEO


Shares of Novavax Inc. NVAX, +13.25% were up about 9% in trading on Monday after the company said John Jacobs will take over as president and CEO on Jan. 23. Jacobs, the former president and CEO of Harmony Biosciences Holdings Inc. HRMY, -14.25%, will replace Stanley Erck, who will continue to advise for the company into 2024. Novavax’s stock has tumbled 90.5% over the past year, while the S&P 500 SPX, +1.39% is down 17.0%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleNeed to Know: Fed’s Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
Next articleCoronavirus Update: China cracks down on critics of government’s COVID approach


Please enter your comment!
Please enter your name here